The formed bcr-abl fusion gene is translated into the BCR-ABL oncoprotein which displays constitutive tyrosine kinase activity and results in CML occurrence and progression [1]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.